Aetiology, pathogenesis, and pathology of cervical neoplasia.

Por Arends, M J, Buckley, C H, Wells, M
Publicado em 1998

Apoptosis. The role of the endonuclease.

Por Arends, M. J., Morris, R. G., Wyllie, A. H.
Publicado em 1990

Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response.

Por Aldridge, D. R., Arends, M. J., Radford, I. R.
Publicado em 1995

Human papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16.

Por Arends, M. J., Wyllie, A. H., Bird, C. C.
Publicado em 1995

Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes.

Por Arends, M. J., McGregor, A. H., Wyllie, A. H.
Publicado em 1994

PCR analysis of the upstream regulatory region of human papillomavirus genomes in cervical intraepithelial neoplasia and cervical carcinoma.

Por Donaldson, Y K, Arends, M J, Duvall, E, Bird, C C
Publicado em 1993

Sensitivity of digoxigenin and biotin labelled probes for detection of human papillomavirus by in situ hybridisation.

Por Morris, R G, Arends, M J, Bishop, P E, Sizer, K, Duvall, E, Bird, C C
Publicado em 1990

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.

Por Arends, M. J., McGregor, A. H., Toft, N. J., Brown, E. J., Wyllie, A. H.
Publicado em 1993

A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded...

Por Scott, I S, Heath, T M, Morris, L S, Rushbrook, S M, Bird, K, Vowler, S L, Arends, M J, Coleman, N
Publicado em 2004

Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study

Por Cuschieri, K S, Cubie, H A, Whitley, M W, Gilkison, G, Arends, M J, Graham, C, McGoogan, E
Publicado em 2005

Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18

Por Cubie, H A, Seagar, A L, McGoogan, E, Whitehead, J, Brass, A, Arends, M J, Whitley, M W
Publicado em 2001

Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenita...

Por Arends, M. J., Benton, E. C., McLaren, K. M., Stark, L. A., Hunter, J. A., Bird, C. C.
Publicado em 1997

Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population

Por Cuschieri, K S, Cubie, H A, Whitley, M W, Seagar, A L, Arends, M J, Moore, C, Gilkisson, G, McGoogan, E
Publicado em 2004

Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.

Por Stark, L. A., Arends, M. J., McLaren, K. M., Benton, E. C., Shahidullah, H., Hunter, J. A., Bird, C. C.
Publicado em 1994

Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.

Por Stark, L. A., Arends, M. J., McLaren, K. M., Benton, E. C., Shahidullah, H., Hunter, J. A., Bird, C. C.
Publicado em 1994

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours

Por Özdağ, H, Batley, S J, Försti, A, Iyer, N G, Daigo, Y, Boutell, J, Arends, M J, Ponder, B A J, Kouzarides, T, Caldas, C
Publicado em 2002

Loss of Rassf1a co-operates with Apc(Min) to accelerate intestinal tumourigenesis

Por van der Weyden, L., Arends, M.J., Dovey, O.M., Harrison, H. L., Lefebvre, G., Conte, N., Gergely, F.V., Bradley, A., Adams, D.J.
Publicado em 2008

The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis

Por van der Weyden, L., Tachibana, K. K., Gonzalez, M. A., Adams, D. J., Ng, B. L., Petty, R., Venkitaraman, A. R., Arends, M. J., Bradley, A.
Publicado em 2005

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity

Por van der Weyden, L, Rust, A G, McIntyre, R E, Robles-Espinoza, C D, del Castillo Velasco-Herrera, M, Strogantsev, R, Ferguson-Smith, A C, McCarthy, S, Keane, T M, Arends, M J, Adams, D J
Publicado em 2013